Transaction mix for orphan assets has shifted toward partnerships and earlier licensing, while orphan M&A remains comparatively resilient and increasingly reflects scarcity of late-stage, ...

Collaboration Aims to Establish Sustainable Access to a Newly Approved Therapy Targeting a Rare Immunodeficiency, Filling Urgent Gap Left by For-Profit Efforts CAMBRIDGE, Mass. and ROME, Dec. 15, 2025 ...